NYSE:CNC Centene (CNC) Stock Price, News & Analysis $78.40 +0.24 (+0.31%) (As of 08/21/2024 ET) Add Compare Share Share Today's Range$78.13▼$78.7650-Day Range$64.87▼$78.5152-Week Range$60.83▼$81.42Volume2.83 million shsAverage Volume3.47 million shsMarket Capitalization$41.84 billionP/E Ratio15.59Dividend YieldN/APrice Target$84.36 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Centene alerts: Email Address Centene MarketRank™ Stock AnalysisAnalyst RatingHold2.40 Rating ScoreUpside/Downside7.6% Upside$84.36 Price TargetShort InterestHealthy2.01% of Float Sold ShortDividend StrengthN/ASustainability-0.26Upright™ Environmental ScoreNews Sentiment0.47Based on 28 Articles This WeekInsider TradingN/AProj. Earnings Growth9.06%From $6.84 to $7.46 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.41 out of 5 starsMedical Sector110th out of 924 stocksHealthcare Plans Industry1st out of 1 stocks 2.2 Analyst's Opinion Consensus RatingCentene has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 6 buy ratings, 9 hold ratings, and no sell ratings.Amount of Analyst CoverageCentene has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Centene's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted2.01% of the float of Centene has been sold short.Short Interest Ratio / Days to CoverCentene has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Centene has recently decreased by 22.82%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldCentene does not currently pay a dividend.Dividend GrowthCentene does not have a long track record of dividend growth. Previous Next 3.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreCentene has received a 52.32% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Health insurance services for individuals", "Commercial health insurance services", and "Health insurance services for groups" products. See details.Environmental SustainabilityThe Environmental Impact score for Centene is -0.26. Previous Next 1.9 News and Social Media Coverage News SentimentCentene has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 28 news articles for Centene this week, compared to 14 articles on an average week.Search InterestOnly 8 people have searched for CNC on MarketBeat in the last 30 days. This is a decrease of -27% compared to the previous 30 days.MarketBeat FollowsOnly 6 people have added Centene to their MarketBeat watchlist in the last 30 days. This is a decrease of -25% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Centene insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.33% of the stock of Centene is held by insiders.Percentage Held by Institutions93.63% of the stock of Centene is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Centene's insider trading history. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Centene are expected to grow by 9.06% in the coming year, from $6.84 to $7.46 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Centene is 15.59, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 145.43.Price to Earnings Ratio vs. SectorThe P/E ratio of Centene is 15.59, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 139.34.Price to Earnings Growth RatioCentene has a PEG Ratio of 1.00. PEG Ratios around 1 indicate that a company is correctly valued.Price to Book Value per Share RatioCentene has a P/B Ratio of 1.50. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Centene's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Colonial MetalsWanted Dead: PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.In answer to this issue, we have released a Special Report to the public. About Centene Stock (NYSE:CNC)Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.Read More CNC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CNC Stock News HeadlinesAugust 20 at 9:59 AM | seekingalpha.comManage Centene Corp. Conservatively Like They Manage Their MoneyAugust 20 at 4:56 AM | americanbankingnews.comCentene (NYSE:CNC) Given "Overweight" Rating at Cantor FitzgeraldAugust 22, 2024 | Paradigm Press (Ad)US developing “superweapon” to defeat China and Russia?Our new superweapon is a gift to every patriot. I predict the devastating new tech behind this weapon will create the greatest investment opportunity for Americans since WWII. Similar stocks in the past have seen peak gains of 16,270%in just 18 months.August 20 at 3:14 AM | americanbankingnews.comBrokers Offer Predictions for Centene Co.'s FY2024 Earnings (NYSE:CNC)August 20 at 1:50 AM | seekingalpha.comCentene Corporation: Strategic Market Position Amid Favorable Trends, BuyAugust 19 at 5:38 PM | benzinga.comExpert Ratings For CenteneAugust 19 at 5:38 PM | marketwatch.comCentene Corp. stock rises Monday, still underperforms marketAugust 18, 2024 | ca.finance.yahoo.comCNC Aug 2024 78.000 putAugust 22, 2024 | Paradigm Press (Ad)US developing “superweapon” to defeat China and Russia?Our new superweapon is a gift to every patriot. I predict the devastating new tech behind this weapon will create the greatest investment opportunity for Americans since WWII. Similar stocks in the past have seen peak gains of 16,270%in just 18 months.August 17, 2024 | ca.finance.yahoo.comCNC Aug 2024 59.000 putAugust 17, 2024 | ca.finance.yahoo.comCNC Aug 2024 100.000 callAugust 17, 2024 | americanbankingnews.comQ3 2024 Earnings Forecast for Centene Co. (NYSE:CNC) Issued By Zacks ResearchAugust 16, 2024 | marketwatch.comCentene Corp. stock underperforms Friday when compared to competitorsAugust 16, 2024 | bizjournals.comCentene to drop 37K Medicare Advantage enrolleesAugust 15, 2024 | prnewswire.comCENTENE ANNOUNCES THE ELECTION OF THOMAS GRECO TO BOARD OF DIRECTORSAugust 14, 2024 | marketwatch.comCentene Corp. stock rises Tuesday, still underperforms marketAugust 14, 2024 | americanbankingnews.comCentene Co. (NYSE:CNC) Receives $84.36 Average Price Target from AnalystsAugust 13, 2024 | prnewswire.comSuperior HealthPlan Awards $24,000 in Grants to 12 Nonprofits and ProvidersSee More Headlines Receive CNC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Centene and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings7/26/2024Today8/22/2024Next Earnings (Estimated)10/22/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Healthcare Plans Sub-IndustryManaged Health Care Current SymbolNYSE:CNC CUSIP15135B10 CIK1071739 Webwww.centene.com Phone(314) 725-4477Fax314-558-2428Employees67,700Year Founded1984Price Target and Rating Average Stock Price Target$84.36 High Stock Price Target$104.00 Low Stock Price Target$69.00 Potential Upside/Downside+7.6%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage15 Analysts Profitability EPS (Most Recent Fiscal Year)$5.03 Trailing P/E Ratio15.59 Forward P/E Ratio11.46 P/E Growth1Net Income$2.70 billion Net Margins1.79% Pretax Margin2.40% Return on Equity14.45% Return on Assets4.57% Debt Debt-to-Equity Ratio0.64 Current Ratio1.17 Quick Ratio1.17 Sales & Book Value Annual Sales$157.75 billion Price / Sales0.27 Cash Flow$9.30 per share Price / Cash Flow8.43 Book Value$52.17 per share Price / Book1.50Miscellaneous Outstanding Shares533,656,000Free Float531,895,000Market Cap$41.84 billion OptionableOptionable Beta0.50 Social Links These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMs. Sarah M. London (Age 43)CEO & Director Comp: $4.98MMr. Kenneth John Fasola (Age 64)President Comp: $4.67MMr. Andrew Lynn Asher (Age 55)Executive VP & CFO Comp: $3.37MMr. Christopher Andrew Koster (Age 59)Executive VP, General Counsel & Secretary Comp: $2.25MMr. David P. Thomas (Age 58)CEO of Markets & Medicaid Comp: $2.86MMs. Susan R. Smith (Age 48)Chief Operating Officer Ms. Katie Nicole Casso (Age 42)Senior VP, Chief Accounting Officer & Corporate Controller Mr. Brian Phillip LeClaire M.B.A. (Age 64)Ph.D., Chief Information Officer Ms. Jennifer Lynch GilliganSenior Vice President of Investor RelationsMs. Ashlee KnuckeyChief Risk, Ethics & Compliance OfficerMore ExecutivesKey CompetitorsElevance HealthNYSE:ELVThe Cigna GroupNYSE:CIHumanaNYSE:HUMMolina HealthcareNYSE:MOHUnitedHealth GroupNYSE:UNHView All CompetitorsInsiders & InstitutionsTruist Financial CorpSold 96,196 shares on 8/21/2024Ownership: 0.054%Granite Bay Wealth Management LLCBought 3,100 shares on 8/21/2024Ownership: 0.001%Point72 Asset Management L.P.Sold 21,400 shares on 8/19/2024Ownership: 0.000%B. Riley Wealth Advisors Inc.Sold 1,291 shares on 8/19/2024Ownership: 0.001%Northwestern Mutual Wealth Management Co.Bought 2,565 shares on 8/16/2024Ownership: 0.071%View All Insider TransactionsView All Institutional Transactions Should I Buy Centene Stock? CNC Pros and Cons Explained Pros Here are some ways that investors could benefit from investing in Centene Co.: Centene's stock price has been showing a consistent upward trend, indicating potential for capital appreciation. The company has a strong market capitalization of $41.68 billion, reflecting stability and investor confidence. Centene's recent quarterly earnings report showed a revenue increase of 5.9%, demonstrating growth and financial health. Institutional investors, such as Norges Bank and Swedbank AB, have made significant investments in Centene, signaling trust in the company's future prospects. Analysts have given Centene an average rating of "Moderate Buy" with a price target of $84.36, suggesting potential for further stock price appreciation. Cons Investors should be bearish about investing in Centene Co. for these reasons: Centene's debt-to-equity ratio of 0.64 may indicate higher financial leverage, which could pose risks during economic downturns. The company's PE ratio of 15.55 is relatively higher compared to industry peers, potentially signaling overvaluation. There have been recent insider sales of Centene stock by company directors, which could raise concerns about future performance. Centene's beta of 0.50 suggests lower volatility compared to the market, which may limit potential returns for more risk-seeking investors. The company's quick ratio and current ratio of 1.17 each may indicate limited liquidity, which could impact the company's ability to meet short-term obligations. These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, August 18, 2024. Please send any questions or comments about these Centene pros and cons to contact@marketbeat.com. CNC Stock Analysis - Frequently Asked Questions How have CNC shares performed this year? Centene's stock was trading at $74.21 at the start of the year. Since then, CNC stock has increased by 5.6% and is now trading at $78.40. View the best growth stocks for 2024 here. How were Centene's earnings last quarter? Centene Co. (NYSE:CNC) released its quarterly earnings results on Friday, July, 26th. The company reported $2.42 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.44 by $0.02. Centene's quarterly revenue was up 5.9% on a year-over-year basis. Read the conference call transcript. When did Centene's stock split? Centene's stock split on Wednesday, February 6th 2019. The 2-1 split was announced on Tuesday, February 5th 2019. The newly minted shares were distributed to shareholders after the market closes on Tuesday, February 5th 2019. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. Is Centene doing a stock buyback? Centene's board approved a stock buyback program on Friday, December 16th 2022, which permits the company to buy back $2,000,000,000 in outstanding shares, according to EventVestor. This means that the company could purchase up to 4.3% of its shares through open market purchases. Shares repurchase programs are often an indication that the company's management believes its stock is undervalued. What is Michael F. Neidorff's approval rating as Centene's CEO? 930 employees have rated Centene Chief Executive Officer Michael F. Neidorff on Glassdoor.com. Michael F. Neidorff has an approval rating of 74% among the company's employees. Does Centene have any subsidiaries? Centene subsidiaries include Magellan Health Inc, PANTHERx Rare Pharmacy, Apixio, WellCare Health Plans, Community Medical Group, MHM, Fidelis Care, and more. Who are Centene's major shareholders? Top institutional shareholders of Centene include Swedbank AB (1.90%), Bank of New York Mellon Corp (1.03%), Legal & General Group Plc (0.96%) and Dimensional Fund Advisors LP (0.88%). Insiders that own company stock include Sarah London, Andrew Lynn Asher, Kenneth J Fasola, Shannon Bagley, Christopher J Coughlin, Richard A Gephardt, Theodore R Samuels II, Lori Jean Robinson, John R Roberts, Mark J Brooks, Katie Casso, David P Thomas, Christopher Koster, Michael F Neidorff, Colin A Toney, Orlando Ayala and Brent D Layton. View institutional ownership trends. How do I buy shares of Centene? Shares of CNC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Centene own? Based on aggregate information from My MarketBeat watchlists, some other companies that Centene investors own include NVIDIA (NVDA), Alibaba Group (BABA), UnitedHealth Group (UNH), Micron Technology (MU), CVS Health (CVS), Intel (INTC) and Johnson & Johnson (JNJ). This page (NYSE:CNC) was last updated on 8/22/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredUS developing “superweapon” to defeat China and Russia?Our new superweapon is a gift to every patriot. I predict the devastating new tech behind this weapon will cre...Paradigm Press | SponsoredAir Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could becom...DTI | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredSilver Grab of the Decade?In a groundbreaking move, J.P. Morgan now possesses the largest amount of physical silver in recorded history…...Colonial Metals | SponsoredAmazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | Sponsored625,000% GainThe recent crypto pullback has been brutal, causing widespread panic among investors. But for us, it’s just an...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centene Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Centene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CNC Stock Alerts